The Journal of Organic Chemistry
Featured Article
ethyl acetate. The combined organic layer was dried over sodium
sulfate. Concentration in vacuo and subsequent purification by column
chromatography on silica gel with hexane/ethyl acetate (20/1 v/v) as
an eluent gave 2-[naphthalen-2-yl(phenyl)methyl]benzo[d]oxazole
(3aa; 75.5 mg, 0.23 mmol) in 90% yield.
2.6 Hz, 1H), 7.30 (dd, J = 4.3, 3.3 Hz, 1H), 7.33 (dd, J = 4.4, 3.0 Hz,
1H), 7.44 (dd, J = 1.8, 0.76 Hz, 1H), 7.45−7.52 (m, 3H), 7.57 (dd, J =
8.5, 1.1 Hz, 1H), 7.73−7.77 (m, 1H), 7.79−7.85 (m, 4H) ; 13C{1H}
NMR (100 MHz, CDCl3) δ 46.0, 108.9, 110.6, 110.7, 120.4, 124.4,
125.1, 126.3 (overlapped), 126.4, 127.6, 127.7, 128.1, 128.7, 132.9,
133.4, 134.2, 141.2, 142.7, 151.0, 151.6, 164.7; HRMS (APCI) m/z
([M + H]+) calcd for C22H16NO2 326.1176, found 326.1176.
2-[1-(Naphthalen-2-yl)ethyl]benzo[d]oxazole (3ah). Purified by
column chromatography on silica gel with ethyl acetate/hexane (1/20
v/v) as an eluent; 53 mg (77%): mp 115−116 °C (from ethyl acetate/
hexane); 1H NMR (400 MHz, CDCl3) δ 1.92 (d, J = 7.2 Hz, 3H), 4.58
(q, J = 7.2 Hz, 1H), 7.27 (ddd, J = 7.4, 4.7, 1.6 Hz, 1H), 7.30 (ddd, J =
7.4, 4.7, 1.6 Hz, 1H), 7.42−7.50 (m, 4H), 7.72−7.75 (m, 1H), 7.79−
7.82 (m, 4H); 13C{1H} NMR (100 MHz, CDCl3) δ 19.8, 40.3, 110.5,
119.9, 124.2, 124.7, 125.6, 125.9, 126.1, 126.3, 127.7, 127.9,
128.6, 132.6, 133.5, 138.6, 141.2, 150.9, 168.8; HRMS (APCI) m/z
([M + H]+) calcd for C19H16NO 274.1236, found 274.1226.
2-[Naphthalen-2-yl(phenyl)methyl]benzo[d]oxazole (3aa). Puri-
fied by column chromatography on silica gel with ethyl acetate/hexane
(1/20 v/v) as an eluent; 76 mg (90%): mp 114−115 °C (from ethyl
1
acetate/hexane); H NMR (400 MHz, CDCl3) δ 5.93 (s, 1H), 7.27−
7.40 (m, 7H), 7.43−7.51 (m, 4H), 7.74−7.79 (m, 3H), 7.80−7.83 (m,
2H); 13C{1H} NMR (100 MHz, CDCl3) δ 51.7, 110.7, 120.3, 124.3,
124.9, 126.1, 126.3, 126.9, 127.52, 127.53, 127.6, 128.0, 128.5, 128.8,
128.9, 132.6, 133.4, 136.7, 139.1, 141.3, 151.0, 166.7; HRMS (APCI)
m/z ([M + H]+) calcd for C24H18NO 336.1387, found 336.1383.
2-[(4-Methoxyphenyl)(naphthalen-2-yl)methyl]benzo[d]oxazole
(3ab). Purified by column chromatography on silica gel with ethyl
acetate/hexane (1/5 v/v) as an eluent; 76 mg (83%): mp 113−114 °C
1
(from ethyl acetate/hexane); H NMR (400 MHz, CDCl3) δ 3.79 (s,
2-[Naphthalen-1-yl(phenyl)methyl]benzo[d]oxazole (3ai). Puri-
fied by column chromatography on silica gel with ethyl acetate/hexane
(1/20 v/v) as an eluent; 68 mg (82%): mp 155−156 °C (from ethyl
3H), 5.89 (s, 1H), 6.89 (dd, J = 8.8, 2.1 Hz, 2H), 7.29−7.34 (m, 4H),
7.43−7.52 (m, 4H), 7.72−7.83 (m, 5H); 13C{1H} NMR (100 MHz,
CDCl3) δ 50.9, 55.3, 110.7, 114.2, 120.2, 124.3, 124.9, 126.1, 126.3,
126.8, 127.3, 127.6, 128.0, 128.5, 130.0, 131.2, 132.6, 133.4, 137.0,
141.3, 151.0, 158.9, 167.0; HRMS (APCI) m/z ([M + H]+) calcd for
C25H20NO2 366.1494, found 366.1489.
1
acetate/hexane); H NMR (400 MHz, CDCl3) δ 6.54 (s, 1H), 7.27−
7.38 (m, 8H), 7.39−7.48 (m, 4H), 7.71−7.74 (m, 1H), 7.82 (d, J = 8.4
Hz, 1H), 7.86−7.89 (m, 1H), 8.03−8.06 (m, 1H); 13C{1H} NMR
(100 MHz, CDCl3) δ 48.0, 110.7, 120.3, 123.3, 124.3, 124.9, 125.4,
125.8, 126.7, 126.9, 127.5, 128.4, 128.8, 128.98, 129.02, 131.5, 134.0,
135.0, 138.8, 141.4, 151.0, 167.0; HRMS (APCI) m/z ([M + H]+)
calcd for C24H18NO 336.1383, found 336.1383.
2-[Naphthalen-2-yl(2-methylphenyl)methyl]benzo[d]oxazole
(3ac). Purified by column chromatography on silica gel with ethyl
acetate/hexane (1/5 v/v) as an eluent; 50 mg (58%): mp 125−126 °C
1
(from ethyl acetate/hexane); H NMR (400 MHz, CDCl3) δ 2.34 (s,
2-[Benzo[b]thiophen-3-yl(phenyl)methyl]benzo[d]oxazole(3aj).
Purified by column chromatography on silica gel with ethyl acetate/
hexane (1/20 v/v) as an eluent; 65 mg (76%): mp 154−155 °C (from
3H), 6.10 (s, 1H), 7.16−7.24 (m, 4H), 7.29−7.34 (m, 2H), 7.40−7.49
(m, 4H), 7.64 (s, 1H), 7.73−7.79 (m, 2H), 7.80−7.83 (m, 2H);
13C{1H} NMR (100 MHz, CDCl3) δ 19.8, 48.4, 110.7, 120.3,
1
ethyl acetate/hexane); H NMR (400 MHz, CDCl3) δ 6.07 (s, 1H),
7.27−7.36 (m, 8H), 7.43−7.45 (m, 2H), 7.45−7.50 (m, 1H), 7.62 (d,
J = 7.7 Hz, 1H), 7.71−7.74 (m, 1H), 7.85 (dd, J = 7.2, 1.2 Hz, 1H);
13C{1H} NMR (100 MHz, CDCl3) δ 46.0, 110.7, 120.3, 121.9, 123.0,
124.3, 124.4, 124.6, 125.0, 125.4, 127.8, 128.7, 128.9, 133.3, 137.8,
137.9, 140.5, 141.3, 150.9, 165.9; HRMS (APCI) m/z ([M + H]+)
calcd for C22H16NOS 342.0947, found 342.0953.
124.3, 124.9, 126.1, 126.2, 126.4, 127.1, 127.7 (three signals were
overlapped.), 128.0, 128.5, 128.8, 130.9, 132.6, 133.4, 136.1, 136.5,
137.4, 141.4, 151.0, 166.9; HRMS (APCI) m/z ([M + H]+) calcd for
C25H20NO 350.1539, found 350.1539.
2-[(4-Chlorophenyl)(naphthalen-2-yl)methyl]benzo[d]oxazole
(3ad). Purified by column chromatography on silica gel with
ethyl acetate/hexane (1/20 v/v) as an eluent followed by GPC with
chloroform; 43 mg (47%), oil: 1H NMR (400 MHz, CDCl3) δ 5.89 (s,
1H), 7.30−7.33 (m, 6H), 7.43−7.50 (m, 4H), 7.72−7.82 (m, 5H);
13C{1H} NMR (100 MHz, CDCl3) δ 51.2, 110.7, 120.3, 124.5, 125.1,
2-[Benzofuran-2-yl(phenyl)methyl]benzo[d]oxazole (3ak). Puri-
fied by column chromatography on silica gel with ethyl acetate/hexane
1
(1/20 v/v) as an eluent; 32 mg (39%), oil: H NMR (400 MHz,
CDCl3) δ 5.89 (s, 1H), 6.66 (s, 1H), 7.18−7.27 (m, 2H), 7.31−7.44
(m, 6H), 7.49−7.53 (m, 4H), 7.73−7.77 (m, 1H); 13C{1H} NMR
(100 MHz, CDCl3) δ 46.3, 105.8, 110.8, 111.3, 120.4, 121.1, 122.9,
123.3, 124.3, 124.5, 125.2, 128.2, 128.7, 129.0, 136.2, 141.2, 151.0,
154.7, 155.2, 164.1; HRMS (APCI) m/z ([M + H]+) calcd for
C22H16NO2 326.1176, found 326.1176.
126.3, 126.4, 126.6, 127.5, 127.7, 128.0, 128.7, 129.0, 130.3, 132.7,
133.4, 133.5, 136.2, 137.6, 141.2, 151.0, 166.2; HRMS (APCI) m/z
([M + H]+) calcd for C24H17ClNO 370.0993, found 370.0993.
4-[Benzo[d]oxazol-2-yl(naphthalen-2-yl)methyl]benzonitrile
(3ae). Purified by column chromatography on silica gel with ethyl
acetate/hexane (1/5 v/v) as an eluent; 48 mg (53%): mp 53−54 °C
2-([1,1′-Biphenyl]-4-yl(phenyl)methyl)benzo[d]oxazole (3al). Pu-
rified by column chromatography on silica gel with ethyl acetate/
hexane (1/20 v/v) as an eluent; 37 mg (42%): mp 126−127 °C (from
1
(from ethyl acetate/hexane); H NMR (400 MHz, CDCl3) δ 5.96 (s,
1H), 7.33−7.37 (m, 2H), 7.43 (dd, J = 8.6, 1.8 Hz, 1H), 7.47−7.52
(m, 5H), 7.65 (d, J = 8.4 Hz, 2H), 7.73 (s, 1H), 7.75−7.86 (m, 4H);
13C{1H} NMR (100 MHz, CDCl3) δ 51.5, 110.8, 111.6, 118.6, 120.4,
124.6, 125.4, 126.4, 125.55, 126.63, 127.68, 127.71, 128.0, 129.0,
129.8, 132.6, 132.8, 133.3, 135.3, 141.1, 144.4, 150.9, 165.3; HRMS
(APCI) m/z ([M + H]+) calcd for C25H17N2O 361.1335, found
361.1335.
1
ethyl acetate/hexane); H NMR (400 MHz, CDCl3) δ 5.81 (s, 1H),
7.29−7.44 (m, 12H), 7.48−7.50 (m, 1H), 7.56−7.58 (m, 4H), 7.72−
7.77 (m, 1H); 13C{1H} NMR (100 MHz, CDCl3) δ 51.3, 110.7, 120.3,
124.3, 124.9, 127.1, 127.4, 127.5 (overlapped), 128.77, 128.82, 128.83,
129.2, 138.3, 139.2, 140.4, 140.6, 141.3, 151.0, 166.7; HRMS (APCI)
m/z ([M + H]+) calcd for C26H20NO 362.1539, found 362.1539.
2-[(Diphenyl)methyl]benzo[d]oxazole (3am). Purified by column
chromatography on silica gel with ethyl acetate/hexane (1/20 v/v) as
an eluent; 22 mg (31%): mp 62−63 °C (from ethyl acetate/hexane);
1H NMR (400 MHz, CDCl3) δ 5.77 (s, 1H), 7.27−7.35 (m, 12H),
7.46−7.50 (m, 1H), 7.71−7.76 (m, 1H); 13C NMR (100 MHz,
CDCl3) δ 51.6, 110.7, 120.2, 124.3, 124.9, 127.4, 128.76, 128.81,
139.2, 141.3, 151.0, 166.7; HRMS (APCI) m/z ([M + H]+) calcd for
C20H16NO 286.1226, found 286.1232.
2-[Naphthalen-2-yl(thiophen-2-yl)methyl]benzo[d]oxazole (3af).
Purified by column chromatography on silica gel with ethyl acetate/
hexane (1/20 v/v) as an eluent; 53 mg (62%): mp 102−103 °C (from
1
ethyl acetate/hexane); H NMR (400 MHz, CDCl3) δ 6.12 (s, 1H),
6.99 (dd, J = 5.1, 3.6 Hz, 1H), 7.04−7.05 (m, 1H), 7.29 (dd, J = 5.1,
1.1 Hz, 1H), 7.31−7.35 (m, 2H), 7.45−7.51 (m, 3H), 7.58 (dd, J =
8.5, 1.1 Hz, 1H), 7.75−7.86 (m, 5H); 13C{1H} NMR (100 MHz,
CDCl3) δ 47.1, 110.8, 120.4, 124.4, 125.1, 125.7, 126.28, 126.31,
126.4, 126.9, 127.0, 127.3, 127.7, 128.1, 128.7, 132.8, 133.4, 136.4,
141.2, 141.7, 151.0, 165.8; HRMS (APCI) m/z ([M + H]+) calcd for
C22H16NOS 342.0958, found 342.0947.
2-(Phenyl(thiophen-2-yl)methyl)benzo[d]oxazole (3an). Purified
by column chromatography on silica gel with ethyl acetate/hexane
(1/20 v/v) as an eluent followed by GPC with chloroform; 26 mg
1
2-[Furan-2-yl(naphthalen-2-yl)methyl]benzo[d]oxazole (3ag).
(35%), oil: H NMR (400 MHz, CDCl3) δ 5.96 (s, 1H), 6.97−7.02
Purified by column chromatography on silica gel with ethyl acetate/
(m, 2H), 7.25−7.38 (m, 6H), 7.43−7.45 (m, 2H), 7.48−7.52 (m, 1H),
7.71−7.77 (m, 1H); 13C{1H} NMR (100 MHz, CDCl3) δ 46.9, 110.7,
120.3, 124.4, 125.1, 125.5, 126.82, 126.84, 127.9, 128.4, 128.9, 139.0,
1
hexane (1/20 v/v) as an eluent; 33 mg (40%), oil: H NMR (400
MHz, CDCl3) δ 5.94 (s, 1H), 6.30−6.31 (m, 1H), 6.38 (dd, J = 2.9,
H
dx.doi.org/10.1021/jo5010636 | J. Org. Chem. XXXX, XXX, XXX−XXX